http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2285529-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f45ee3002f4123583edea6895991a6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_072dad81aacf5858cd9044ae13ff082e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01bcbb672d135b6c39d917dc1e9567a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c172daf2461a74d9880e16d50998795 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
| filingDate | 2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c679b61d7a95ddf11cc3013e8df51bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a50a58670f724876e9d822b4efbbc15b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb8e30a696adc6e2821388d7a09e30a |
| publicationDate | 2006-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2285529-C2 |
| titleOfInvention | Method for treatment of aids |
| abstract | FIELD: medicine, infectious diseases. n SUBSTANCE: method involves carrying out the step-by-step treatment wherein the following agents are administrated at the first step in turn: inhibitor and activator of virus replication; hemosorption is carried out at the second step; reablement of immune system is carried out at the third step by using blood enriched with stem cells, and specific immunostimulation. Hemosorption is carried out by using columns wherein each comprises a matrix with agarose-immobilized ligands comprising, respectively: the first - specific antiviral antibodies, the second - CD4-receptors, the third - receptors raised to gamma-interferon, the fourth - receptors raised to Fc-fragment of immunoglobulin G, the fifth - antimicrobial proteins of mammalian origin, and blood enriched with stem cells is administrated by intravenous route. Invention promotes to the maximal sorption of HIV and its elimination, limiting the iatrogenic immunosuppression that, in turn, promotes to reducing risk for virus persistence in the patient body. Invention can be used in treatment of patients with AIDS. n EFFECT: enhanced effectiveness of treatment. |
| priorityDate | 2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545923 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476 |
Total number of triples: 22.